Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BNR Burning Rock Biotech	$5.68 -1.5%	$4.12	$2.18 ▼ $9.48	$61.99M	0.83	54,557 shs	23,623 shs
EUDA EUDA Health	$3.16 +2.6%	$3.40	$2.92 ▼ $6.30	$114.44M	-0.04	90,075 shs	102,030 shs
QIPT Quipt Home Medical	$2.31 +4.5%	$1.96	$1.35 ▼ $3.75	$96.01M	0.59	261,818 shs	270,035 shs
SERA Sera Prognostics	$2.70 -2.9%	$2.32	$1.37 ▼ $9.13	$104.73M	0.99	118,313 shs	59,613 shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BNR Burning Rock Biotech	-1.46%	-16.53%	+75.73%	+103.44%	-22.88%
EUDA EUDA Health	+2.60%	-0.63%	-10.23%	-19.39%	-12.71%
QIPT Quipt Home Medical	+4.52%	+3.59%	+29.78%	+6.45%	-40.16%
SERA Sera Prognostics	-2.88%	-16.92%	+10.20%	-7.22%	-67.43%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BNR Burning Rock Biotech	0.7527 of 5 stars	0.0	4.0	0.6	1.7	0.6
EUDA EUDA Health	0.9231 of 5 stars	0.0	5.0	2.0	0.0	0.6
QIPT Quipt Home Medical	2.0027 of 5 stars	2.3	5.0	1.9	1.7	0.6
SERA Sera Prognostics	0.5164 of 5 stars	0.0	2.0	2.0	2.5	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BNR Burning Rock Biotech	0.00	N/A	N/A	N/A
EUDA EUDA Health	4.00	Strong Buy	N/A	N/A
QIPT Quipt Home Medical	2.50	Moderate Buy	$2.85	23.38% Upside
SERA Sera Prognostics	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest BNR, EUDA, SERA, and QIPT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/14/2025	QIPT Quipt Home Medical	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$6.00 ➝ $4.00
5/13/2025	QIPT Quipt Home Medical	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$4.00 ➝ $1.70

(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BNR Burning Rock Biotech	$70.67M	0.86	N/A	N/A	$7.39 per share	0.77
EUDA EUDA Health	$4.01M	29.27	N/A	N/A	($0.07) per share	-45.14
QIPT Quipt Home Medical	$245.91M	0.41	$1.06 per share	2.17	$2.49 per share	0.93
SERA Sera Prognostics	$80K	1,271.36	N/A	N/A	$1.40 per share	1.93

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BNR Burning Rock Biotech	-$47.49M	-$1.89	N/A	∞	N/A	-45.41%	-38.33%	-25.34%	8/28/2025 (Estimated)
EUDA EUDA Health	-$15.36M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
QIPT Quipt Home Medical	-$6.76M	-$0.21	N/A	N/A	N/A	-3.66%	-8.38%	-3.63%	8/11/2025 (Estimated)
SERA Sera Prognostics	-$32.90M	-$0.94	N/A	N/A	N/A	-28,685.22%	-51.35%	-37.21%	8/6/2025 (Estimated)

Latest BNR, EUDA, SERA, and QIPT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2025	Q3 2025	QIPT Quipt Home Medical	$0.03	N/A	N/A	N/A	$80.37 million	N/A
8/6/2025	Q2 2025	SERA Sera Prognostics	-$0.21	N/A	N/A	N/A	$0.05 million	N/A
6/6/2025	Q1 2025	BNR Burning Rock Biotech	N/A	-$0.17	N/A	-$0.17	N/A	$18.34 million
5/14/2025	Q1 2025	SERA Sera Prognostics	-$0.24	-$0.20	+$0.04	-$0.20	$0.06 million	$0.04 million
5/12/2025	Q2 2025	QIPT Quipt Home Medical	$0.02	-$0.07	-$0.09	-$0.07	$88.29 million	$57.40 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BNR Burning Rock Biotech	N/A	N/A	N/A	N/A	N/A
EUDA EUDA Health	N/A	N/A	N/A	N/A	N/A
QIPT Quipt Home Medical	N/A	N/A	N/A	N/A	N/A
SERA Sera Prognostics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BNR Burning Rock Biotech	N/A	3.02	2.76
EUDA EUDA Health	N/A	0.18	0.15
QIPT Quipt Home Medical	0.76	1.22	0.85
SERA Sera Prognostics	N/A	2.02	2.02

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BNR Burning Rock Biotech	30.03%
EUDA EUDA Health	4.35%
QIPT Quipt Home Medical	42.85%
SERA Sera Prognostics	54.64%

Insider Ownership

Company	Insider Ownership
BNR Burning Rock Biotech	30.30%
EUDA EUDA Health	N/A
QIPT Quipt Home Medical	13.40%
SERA Sera Prognostics	13.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BNR Burning Rock Biotech	1,390	10.76 million	7.50 million	Not Optionable
EUDA EUDA Health	2	37.16 million	N/A	Not Optionable
QIPT Quipt Home Medical	1,200	43.44 million	37.62 million	Optionable
SERA Sera Prognostics	120	37.67 million	32.59 million	Optionable

BNR, EUDA, SERA, and QIPT Headlines

Recent News About These Companies

Sera Prognostics (SERA) Expected to Announce Quarterly Earnings on Wednesday

July 31 at 6:34 AM | marketbeat.com

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025

July 29, 2025 | prnewswire.com

Perkins Capital Management Inc. Takes $522,000 Position in Sera Prognostics, Inc. (NASDAQ:SERA)

July 28, 2025 | marketbeat.com

Sera Prognostics director Mirza sells $552 in stock

July 10, 2025 | investing.com

Sera Prognostics (NASDAQ:SERA) Stock, Insider Trading Activity

June 30, 2025 | benzinga.com

Sera Prognostics: PreTRM Labor Test Should Represent Advance In Risk Assessment

June 30, 2025 | seekingalpha.com

Sera Prognostics, Inc. (NASDAQ:SERA) CEO Sells $32,950.06 in Stock

June 12, 2025 | insidertrades.com

We Think Sera Prognostics (NASDAQ:SERA) Needs To Drive Business Growth Carefully

June 10, 2025 | finance.yahoo.com

sera prognostics announces board elections and auditor ratification

June 7, 2025 | investing.com

After Plunging 43.9% in 4 Weeks, Here's Why the Trend Might Reverse for Sera Prognostics (SERA)

May 29, 2025 | zacks.com

SERA PROGNOSTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

May 29, 2025 | prnewswire.com

Sera Prognostics, Inc.: Sera Prognostics Reports First Quarter 2025 Financial Results

May 26, 2025 | finanznachrichten.de

SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE

May 14, 2025 | prnewswire.com

Sera Prognostics, Inc. (NASDAQ:SERA) Q1 2025 Earnings Call Transcript

May 13, 2025 | msn.com

Down -30.54% in 4 Weeks, Here's Why Sera Prognostics (SERA) Looks Ripe for a Turnaround

May 13, 2025 | zacks.com

Sera Prognostics Inc (SERA) Q1 2025 Earnings Call Transcript

May 11, 2025 | seekingalpha.com

Sera Prognostics, Inc. (NASDAQ:SERA) CFO Sells $15,552.56 in Stock

May 10, 2025 | insidertrades.com

Sera Prognostics, Inc.: Sera Prognostics Appoints Lee Anderson As Chief Commercial Officer

May 9, 2025 | finanznachrichten.de

Earnings call transcript: Sera Prognostics reports Q1 2025 earnings beat

May 9, 2025 | investing.com

Sera Prognostics Reports Q1 Revenues of $38K as Preterm Birth Test Commercialization Progresses

May 9, 2025 | 360dx.com3

What I Wish I Knew: The Truth About Preterm Birth for Black Women

May 9, 2025 | blackdoctor.orgB

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNR, EUDA, SERA, and QIPT Company Descriptions

Burning Rock Biotech NASDAQ:BNR

$5.68 -0.08 (-1.46%)

Closing price 08/1/2025 03:58 PM Eastern

Extended Trading

$5.79 +0.11 (+2.01%)

As of 08/1/2025 07:50 PM Eastern

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.

EUDA Health NASDAQ:EUDA

$3.16 +0.08 (+2.60%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$3.20 +0.04 (+1.27%)

As of 08/1/2025 07:56 PM Eastern

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

Quipt Home Medical NASDAQ:QIPT

$2.31 +0.10 (+4.52%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$2.32 +0.00 (+0.22%)

As of 08/1/2025 05:27 PM Eastern

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Sera Prognostics NASDAQ:SERA

$2.70 -0.08 (-2.88%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$2.72 +0.02 (+0.93%)

As of 08/1/2025 04:10 PM Eastern

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time